• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌A毒素治疗逼尿肌-括约肌协同失调:一项双盲研究。

Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study.

作者信息

Dykstra D D, Sidi A A

机构信息

Department of PM&R, University of Minnesota Hospital and Clinic, Minneapolis.

出版信息

Arch Phys Med Rehabil. 1990 Jan;71(1):24-6.

PMID:2297305
Abstract

The ability of botulinum A toxin to denervate and relax a spastic external urethral sphincter was evaluated in a double-blind study involving five men with high spinal cord injuries and detrusor-sphincter dyssynergia. The sphincter was injected with either a low dose of botulinum A toxin or normal saline once per week for three weeks. Electromyography of the external urethral sphincter indicated denervation in the three patients who received toxin injections. The urethral pressure profile decreased an average of 25cm of water, postvoiding residual volume of urine decreased an average of 125cc, and bladder pressure during voiding decreased to an average of 30cm of water. Bulbosphincteric reflexes were more difficult to obtain, and they showed a decreased amplitude with normal latency. In the two patients who received normal saline injections, parameters were unchanged from baseline values until subsequent injection with botulinum A toxin once per week for three weeks when their responses were similar to those of the other three patients. Mild generalized weakness lasting two to three weeks was noted by three patients after initial toxin injections. The duration of the toxin's effect averaged two months. The results suggest that botulinum A toxin, an inhibitor of acetylcholine release at the neuromuscular junction, may be useful in the treatment of detrusor-sphincter dyssynergia.

摘要

在一项双盲研究中,对5名患有高位脊髓损伤和逼尿肌-括约肌协同失调的男性进行了评估,以确定A型肉毒杆菌毒素使痉挛性尿道外括约肌失神经支配并放松的能力。每周一次向括约肌注射低剂量A型肉毒杆菌毒素或生理盐水,持续三周。尿道外括约肌的肌电图显示,接受毒素注射的3名患者出现了失神经支配。尿道压力曲线平均下降25厘米水柱,排尿后残余尿量平均减少125立方厘米,排尿时膀胱压力平均降至30厘米水柱。球海绵体肌反射更难引出,且潜伏期正常,但幅度降低。在接受生理盐水注射的2名患者中,各项参数在后续每周一次注射A型肉毒杆菌毒素持续三周之前均与基线值无变化,此时他们的反应与其他3名患者相似。3名患者在首次注射毒素后出现了持续两到三周的轻度全身无力。毒素作用的持续时间平均为两个月。结果表明,作为神经肌肉接头处乙酰胆碱释放抑制剂的A型肉毒杆菌毒素,可能对治疗逼尿肌-括约肌协同失调有用。

相似文献

1
Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study.肉毒杆菌A毒素治疗逼尿肌-括约肌协同失调:一项双盲研究。
Arch Phys Med Rehabil. 1990 Jan;71(1):24-6.
2
Effect of single botulinum toxin A injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury.单次注射A型肉毒杆菌毒素至尿道外括约肌治疗脊髓损伤所致逼尿肌-外括约肌协同失调的效果
J Rehabil Med. 2008 Oct;40(9):744-8. doi: 10.2340/16501977-0255.
3
Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients.A型肉毒毒素对脊髓损伤患者逼尿肌-括约肌协同失调的影响
J Urol. 1988 May;139(5):919-22. doi: 10.1016/s0022-5347(17)42717-0.
4
The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.A型肉毒杆菌毒素注射用于治疗神经功能正常儿童的外括约肌协同失调。
J Urol. 2007 Oct;178(4 Pt 2):1775-9; discussion 1779-80. doi: 10.1016/j.juro.2007.03.185. Epub 2007 Aug 17.
5
Botulinum toxin as a new therapy option for voiding disorders: current state of the art.肉毒杆菌毒素作为治疗排尿障碍的一种新的治疗选择:当前的技术水平
Eur Urol. 2003 Aug;44(2):165-74. doi: 10.1016/s0302-2838(03)00250-1.
6
Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion.脊髓损伤患者肉毒杆菌毒素A尿道注射治疗逼尿肌括约肌协同失调的满意度
Neurourol Urodyn. 2008;27(8):793-6. doi: 10.1002/nau.20606.
7
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.110例患者膀胱或尿道注射A型肉毒杆菌毒素的单机构经验。
Urology. 2005 Jan;65(1):37-41. doi: 10.1016/j.urology.2004.08.016.
8
Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance.经会阴注射A型肉毒杆菌毒素治疗逼尿肌括约肌协同失调:透视与肌电图联合引导定位
Arch Phys Med Rehabil. 2009 May;90(5):832-6. doi: 10.1016/j.apmr.2008.10.023.
9
Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction.注射肉毒杆菌毒素至尿道括约肌以恢复排尿功能障碍男性和女性的膀胱排空。
J Urol. 2001 Apr;165(4):1107-10.
10
Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction.特发性逼尿肌收缩力低下和排尿功能障碍患者尿道注射A型肉毒杆菌毒素后逼尿肌功能的恢复
Urology. 2007 Jan;69(1):57-61; discussion 61-2. doi: 10.1016/j.urology.2006.08.1117.

引用本文的文献

1
[Neurogenic lower urinary tract dysfunction following spinal cord injury].脊髓损伤后神经源性下尿路功能障碍
Urologie. 2025 Feb;64(2):108-119. doi: 10.1007/s00120-024-02494-1. Epub 2025 Jan 12.
2
Guidelines of Guidelines: Conservative, Pharmacological, and Surgical Management for Neurogenic Lower Urinary Tract Dysfunction.指南之指南:神经源性下尿路功能障碍的保守、药物及手术治疗
Urol Res Pract. 2024 Mar 31;50(2):139-47. doi: 10.5152/tud.2024.23232.
3
Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan.
台湾地区使用微创和手术疗法治疗神经源性下尿路功能障碍脊髓损伤患者的管理
Int Urol Nephrol. 2024 Apr;56(4):1205-1216. doi: 10.1007/s11255-023-03884-8. Epub 2023 Nov 30.
4
The Efficacy and Safety of Intrasphincteric Botulinum Toxin-A Injections in Patients with Non-Spinal Cord Injury-Related Detrusor Sphincter Dyssynergia: A Retrospective Study.肉毒杆菌毒素A括约肌内注射治疗非脊髓损伤相关性逼尿肌括约肌协同失调患者的疗效与安全性:一项回顾性研究
Biomedicines. 2023 Nov 10;11(11):3016. doi: 10.3390/biomedicines11113016.
5
Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children.膀胱内注射A型肉毒杆菌毒素治疗儿童难治性膀胱过度活动症的疗效
J Pers Med. 2023 Mar 31;13(4):616. doi: 10.3390/jpm13040616.
6
Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients-When Intravesical Botox Injection or Urethral Botox Injection Are Indicated.治疗慢性脊髓损伤患者的神经原性下尿路功能障碍——何时需要膀胱内肉毒杆菌毒素注射或尿道肉毒杆菌毒素注射。
Toxins (Basel). 2023 Apr 17;15(4):288. doi: 10.3390/toxins15040288.
7
Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most?尿道括约肌肉毒毒素 A 注射治疗非脊髓损伤伴排尿功能障碍且无解剖梗阻患者:哪些患者获益最大?
Toxins (Basel). 2023 Jan 17;15(2):87. doi: 10.3390/toxins15020087.
8
Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection.不同排尿功能障碍亚型患者接受尿道括约肌肉毒毒素注射治疗结局成功的预测因素。
Toxins (Basel). 2022 Dec 15;14(12):877. doi: 10.3390/toxins14120877.
9
Bladder Management Strategies for Urological Complications in Patients with Chronic Spinal Cord Injury.慢性脊髓损伤患者泌尿系统并发症的膀胱管理策略
J Clin Med. 2022 Nov 20;11(22):6850. doi: 10.3390/jcm11226850.
10
Chinese botulinum toxin A for the treatment of lower urinary tract dysfunction: It works just as well.中国产A型肉毒杆菌毒素治疗下尿路功能障碍:效果同样良好。
Bladder (San Franc). 2022 Sep 14;9(1):e47. doi: 10.14440/bladder.2022.847. eCollection 2022.